An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Thomas H. Lee Partners Appoints Paul Black As a Consultant for Healthcare Group
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
management
Rhea-AI Summary
Thomas H. Lee Partners announced the appointment of Paul Black as a consultant for its healthcare investment group. With over 25 years in healthcare IT, Black will assist in identifying and growing investment opportunities. His past roles include CEO of Allscripts (MDRX) and COO of Cerner (CERN). Shahab Vagefi, Managing Director at THL, emphasized Black's experience will enhance their strategy focused on healthcare technology investments. THL has raised over $34 billion and has a history of successful healthcare investments.
Positive
Paul Black's extensive experience in healthcare IT will enhance THL's investment strategy.
THL's established track record in healthcare investments positions it for future growth.
Negative
No concerns noted.
Healthcare IT Industry Expert Will Support the Firm’s HCIT Strategy
BOSTON--(BUSINESS WIRE)--
Thomas H. Lee Partners, L.P.(“THL”), a premier private equity firm investing in middle-market growth companies, today announced the appointment of Paul Black as a consultant for the firm’s healthcare investment group. Black, who brings more than 25 years of experience leading companies in healthcare information technology (“Healthcare IT”), will support the team’s efforts in identifying, sourcing, and growing investment opportunities across the healthcare market.
“We are very pleased to welcome Paul to THL as a consultant for the firm’s healthcare group,” said Shahab Vagefi, Managing Director at THL. “THL has had a longstanding focus in healthcare and technology. As we continue finding investment opportunities at the intersection of these industries, Paul’s significant experience creating and executing a strategic vision for businesses in Healthcare IT will be greatly beneficial as we add more high-quality companies seeking to improve the healthcare ecosystem to our portfolio.”
In this role, Black will support the healthcare group in deal sourcing, due diligence for potential investments, and developing new relationships with founders and management teams across the healthcare landscape. He will also serve as an advisor to portfolio companies to support their growth.
“THL’s thesis-driven approach and dedicated focus on Healthcare IT has enabled it to work with unique companies across the healthcare landscape,” said Paul Black. “I am pleased to join such an exceptional team and look forward to advancing the firm’s strategy.”
Prior to joining THL, Black served 10 years as a Director and CEO of Allscripts, (NASDAQ:MDRX) a global leader in healthcare information technology solutions. Before that, he was the COO of Cerner Corporation (NASDAQ:CERN) for more than a decade. Black is currently a director of HealthEquity (NASDAQ:HQY), Community CareLink, The Advancement Board University of Kansas Health System and The Harry S. Truman Presidential Library & Museum.
About Thomas H. Lee Partners, L.P.
Thomas H. Lee Partners, L.P. (“THL”) is a premier private equity firm investing in middle-market growth companies exclusively within three sectors: Healthcare, Financial Technology & Services, and Technology & Business Solutions. THL couples deep sector expertise through an Identified Sector Opportunity (“ISO”) process with dedicated internal operating resources from its Strategic Resource Group (“SRG”) to transform and build great companies of lasting value in partnership with management. The Firm’s domain expertise and resources help to build great companies with an aim to accelerate growth, improve operations and drive long-term sustainable value. THL has been an active investor in Healthcare and Healthcare IT for decades with investments in Intelligent Medical Objects, Nextech, Qventus, Intermedix, SeniorLink and numerous other Healthcare and Technology companies. Since 1974, THL has raised more than $34 billion of equity capital, invested in over 160 companies and completed more than 500 add-on acquisitions representing an aggregate enterprise value at acquisition of over $210 billion.
